• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MENTOR TEXAS ARTOURA BREAST TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MENTOR TEXAS ARTOURA BREAST TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE Back to Search Results
Model Number TEXP140RH
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Code Available (3191)
Date of Event 11/04/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The mentor failure analysis lab has received the device for evaluation.The analysis has begun but is not complete at this time.When the investigational analysis has been completed, a supplemental report will be submitted.A manufacturing record evaluation is in progress.Once completed, a supplemental report will be submitted.Reason for device explant and/or reoperation: deflation.Manufacturer¿s reference number: (b)(4).
 
Event or Problem Description
It was reported that a (b)(6) year-old female patient who underwent breast reconstruction surgery with a 600cc artoura breast tissue expander experienced deflation (side unknown) post procedure.As a result, patient had an explantation on (b)(6) 2019.
 
Additional Manufacturer Narrative
The investigation of the returned device was completed by the failure analysis lab on 1/20/2020.Device evaluation summary: according to the information provided, it was reported that the patient experienced a deflation on the breast tissue expander.The device was visually inspected and it was found with no apparent damage.Leak testing revealed a tear in the patch in the posterior view measuring less than 0.1 cm.No other anomalies were observed.Microscopic examination of the edges of the tear gave no indications of instrument damage.No other anomalies observed.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Deflation is a known complication associated with mentor mammary tissue expander.Possible causes of deflation of tissue expander include, but are not limited to the following events: excessive stresses or manipulations as may occur during normal, daily routines including customary and purposeful trauma to the breast.Manufacturer¿s reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTOURA BREAST TISSUE EXPANDER
Common Device Name
EXPANDER, SKIN, INFLATABLE
Manufacturer (Section D)
MENTOR TEXAS
3041 skyway circle north
irving TX 75038
MDR Report Key9508836
Report Number1645337-2019-26031
Device Sequence Number2703931
Product Code LCJ
UDI-Device Identifier00081317009498
UDI-Public00081317009498
Combination Product (Y/N)N
Initial Reporter StateVA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2019
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 11/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/13/2023
Device Model NumberTEXP140RH
Device Catalogue NumberTEXP140RH
Device Lot Number7672993
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/14/2019
Initial Date Received by Manufacturer 11/26/2019
Supplement Date Received by Manufacturer01/20/2020
Initial Report FDA Received Date12/22/2019
Supplement Report FDA Received Date01/21/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age32 YR
-
-